CTI BioPharma Statistics
Total Valuation
Thermo Fisher has a market cap or net worth of $176.55 billion. The enterprise value is $205.39 billion.
Important Dates
The last earnings date was Wednesday, July 23, 2025, before market open.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Sep 15, 2025 |
Share Statistics
Thermo Fisher has 377.49 million shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 377.49M |
| Shares Outstanding | 377.49M |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 91.40% |
| Float | 376.67M |
Valuation Ratios
The trailing PE ratio is 27.04 and the forward PE ratio is 19.93. Thermo Fisher's PEG ratio is 2.54.
| PE Ratio | 27.04 |
| Forward PE | 19.93 |
| PS Ratio | 4.11 |
| Forward PS | 3.88 |
| PB Ratio | 3.50 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.61 |
| P/OCF Ratio | 23.30 |
| PEG Ratio | 2.54 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.97, with an EV/FCF ratio of 33.29.
| EV / Earnings | 31.19 |
| EV / Sales | 4.75 |
| EV / EBITDA | 18.97 |
| EV / EBIT | 25.81 |
| EV / FCF | 33.29 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.93 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 5.71 |
| Interest Coverage | 5.77 |
Financial Efficiency
Return on equity (ROE) is 13.42% and return on invested capital (ROIC) is 5.89%.
| Return on Equity (ROE) | 13.42% |
| Return on Assets (ROA) | 4.98% |
| Return on Invested Capital (ROIC) | 5.89% |
| Return on Capital Employed (ROCE) | 8.99% |
| Revenue Per Employee | $345,696 |
| Profits Per Employee | $52,672 |
| Employee Count | 125,000 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 4.73 |
Taxes
In the past 12 months, Thermo Fisher has paid $436.00 million in taxes.
| Income Tax | 436.00M |
| Effective Tax Rate | 6.21% |
Stock Price Statistics
The stock price has decreased by -23.96% in the last 52 weeks. The beta is 0.75, so Thermo Fisher's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -23.96% |
| 50-Day Moving Average | 419.50 |
| 200-Day Moving Average | 492.33 |
| Relative Strength Index (RSI) | 61.85 |
| Average Volume (20 Days) | 3,291,365 |
Short Selling Information
The latest short interest is 3.83 million, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 3.83M |
| Short Previous Month | 4.91M |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 1.39 |
Income Statement
In the last 12 months, Thermo Fisher had revenue of $43.21 billion and earned $6.58 billion in profits. Earnings per share was $17.30.
| Revenue | 43.21B |
| Gross Profit | 17.80B |
| Operating Income | 7.96B |
| Pretax Income | 6.82B |
| Net Income | 6.58B |
| EBITDA | 10.83B |
| EBIT | 7.96B |
| Earnings Per Share (EPS) | $17.30 |
Full Income StatementBalance Sheet
The company has $6.39 billion in cash and $35.23 billion in debt, giving a net cash position of -$28.84 billion or -$76.40 per share.
| Cash & Cash Equivalents | 6.39B |
| Total Debt | 35.23B |
| Net Cash | -28.84B |
| Net Cash Per Share | -$76.40 |
| Equity (Book Value) | 50.60B |
| Book Value Per Share | 133.53 |
| Working Capital | 11.87B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.58 billion and capital expenditures -$1.41 billion, giving a free cash flow of $6.17 billion.
| Operating Cash Flow | 7.58B |
| Capital Expenditures | -1.41B |
| Free Cash Flow | 6.17B |
| FCF Per Share | $16.34 |
Full Cash Flow StatementMargins
Gross margin is 41.19%, with operating and profit margins of 18.42% and 15.24%.
| Gross Margin | 41.19% |
| Operating Margin | 18.42% |
| Pretax Margin | 16.25% |
| Profit Margin | 15.24% |
| EBITDA Margin | 25.06% |
| EBIT Margin | 18.42% |
| FCF Margin | 14.28% |
Dividends & Yields
This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | 10.53% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 9.71% |
| Buyback Yield | 1.30% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 3.73% |
| FCF Yield | 3.49% |
Dividend DetailsAnalyst Forecast
The average price target for Thermo Fisher is $587.65, which is 25.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $587.65 |
| Price Target Difference | 25.65% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.05% |
| EPS Growth Forecast (5Y) | 15.04% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 6, 1996. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jun 6, 1996 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
